Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

Delayed Quote. Delayed  - 04/29 10:00:00 pm
5.61 USD   -4.43%
04/12 OSIRIS THERAPEU : to Present 15 Advanced Clinical and Scientific Abs..
04/12 OSIRIS THERAPEU : to Present 15 Advanced Clinical and Scientific Abs..
04/08 OSIRIS THERAPEU : Announces Further Expansion of Grafix Commercial C..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
6.14(c) 6.09(c) 5.93(c) 5.87(c) 5.61(c) Last
118 745 75 849 169 663 146 420 68 778 Volume
-0.32% -0.81% -2.63% -1.01% -4.43% Change
More quotes
Financials ($)
Sales 2015 94,9 M
EBIT 2015 4,40 M
Net income 2015 2,77 M
Debt 2015 -
Yield 2015 -
Sales 2016 110 M
EBIT 2016 5,03 M
Net income 2016 4,54 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 73,38
P/E ratio 2016 46,96
Capi. / Sales 2015 2,13x
Capi. / Sales 2016 1,84x
Capitalization 202 M
More Financials
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, and tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on December... 
More about the company
Surperformance© ratings of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on OSIRIS THERAPEUTICS, INC.
04/21 OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts
04/12 OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts
04/12 OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts
04/08 OSIRIS THERAPEUTICS : Announces Further Expansion of Grafix Commercial Coverage
03/23 OSIRIS THERAPEUTICS : receives deficiency notice from Nasdaq
03/22 OSIRIS THERAPEUTICS : Announces Receipt of Deficiency Letter from NASDAQ
03/22 OSIRIS THERAPEUTICS : Notice of Delisting or Failure to Satisfy a Continued List..
03/18 OSIRIS THERAPEUTICS : to Present at the 4th Annual Cell and Gene Therapy Investo..
More news
Sector news : Bio Therapeutic Drugs
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/24 Osiris Therapeutics Beset By Newer And Bigger Troubles
03/22 Osiris deficient with Nasdaq over late 10-K
03/16 Osiris unable to file 2015 annual report due to accounting errors; shares dow..
02/05 Osiris chief exit reinforces problems at company
02/03 Osiris chief bids adieu


Comments 
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions